Results 171 to 180 of about 38,488 (237)

Risks of Smallpox Vaccination [PDF]

BMJ, 1962
openaire   +3 more sources

Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine

, 2008
Joseph W. Golden, Jay W. Hooper
openalex   +1 more source

Smallpox vaccines for biodefense: need and feasibility

, 2008
Andrew W. Artenstein, John D. Grabenstein   +1 more
openalex   +2 more sources

Mpox Epidemics: A Call to Restore Humanity's Lost Herd Immunity to Orthopoxviruses. [PDF]

Viruses
Wayengera M, Kyobe-Bosa H, Muttamba W, Olu OO, Gueye AS, Ndembi N, Kamara N, Folayan MO, Kirenga B, Luo S, Li Q, Ihekweazu C.   +11 more
europepmc   +1 more source

Sero-neutralizing antibody against orthopoxviruses in populations of Wuhan, China. [PDF]

Mol Biomed
Gao Z, Liu T, Zhao Z, Wang B, Hou L.
europepmc   +1 more source

Genomic variability and immunological aspects involved in response to MPXV infection. [PDF]

Front Pharmacol
La Frazia S, Garbuglia AR, Pauciullo S, Zulian V, Del Porto P.   +4 more
europepmc   +1 more source

Fluoridation - Is It Constitutional? No [PDF]

, 1955

core   +1 more source

Neurological complications of Orthopoxvirus infections: neurotropism and neurovirulence. [PDF]

Brain
Miranzadeh Mahabadi H, Noyce RS, Evans DH, Power C.   +3 more
europepmc   +1 more source

Vaccination strategies to achieve outbreak control for MPXV Clade I with a one-time mass campaign in sub-Saharan Africa: A scenario-based modelling study. [PDF]

PLoS Med
Jin S, Asakura TR, Murayama H, Niyukuri D, Saila-Ngita D, Lim JT, Endo A, Dickens BL.   +7 more
europepmc   +1 more source

Evolving Threats: Adaptive Mechanisms of Monkeypox Virus (MPXV) in the 2022 Global Outbreak and Their Implications for Vaccine Strategies. [PDF]

Viruses
Wang Y, Hai M, Guo Z, Wang J, Li Y, Gao W.   +5 more
europepmc   +1 more source